Some studies [9–16] have indicated that there is a positive correlation between the HO-1 (GT)n repeat length polymorphism and CHD, while other studies [17–20] have suggested that alterations in HO-1 expression play no obvious role in the pathogenesis of CHD. This evidence concerns the gene HMOX1 and coronary artery disorder.